MedWatch

Think tank predicts life science sector role to grow as EU struggles to stay innovative

The life science sector will have a central role in a comprehensive revision of the EU’s industry policy, but a new presidency of the European Council could slow down the process, warns a Think Tank Europa representative.

(ILLUSTRATION / ARKIV) | Photo: Saniona / PR

BRUSSELS – An increasing need to become independent in the healthcare area alongside ambitions to retain innovation in Europe will advantage the pharmaceutical industry as new framework conditions are outlined in Brussels, assesses Senior Fellow at Think Tank Europa Ditte Maria Brasso Sørensen.

She spots an opportunity for European life science when EU officials next year begin the extensive work revising its industry policy, and she points out how both the pandemic and the war in Ukraine have turned the spotlight on developing in addition to the independency of third-party countries.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs